Tuesday, January 17, 2023 12:48:31 PM
The are part-time reviewers and full time medical specialists. Peer reviewers are limited in their time and in the information provided to them by the article sponsors. There are already a JAMA Oncology comment and a Journal of Neuro-Oncology Editorial (leading Neuro-Oncology journal) challenging the publication also they are prepared by Neuro-Oncologists with significant credentials and credibility. Link tot he editorial:
https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noac281/6958519?login=false
One key is the issue of a company employed Corresponding Author, Dr. Bosch who is a significant NWBO shareholder. A journal article that studied errors in journal article stated:
"Errors in the articles published in medical journals are common and longstanding. As far back as 1950, librarians were debating how to correct errors in medical journals. We have seen considerable progress in this area in recent decades and most journals now have policies to correct errors, as well as for dealing with fraud and scientific misconduct, in research articles."
These JAMA Oncology comments and the Journal of Neuro-Oncology Editorial both source of and support the comments that I have made.
https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noac281/6958519?login=false
One key is the issue of a company employed Corresponding Author, Dr. Bosch who is a significant NWBO shareholder. A journal article that studied errors in journal article stated:
"Errors in the articles published in medical journals are common and longstanding. As far back as 1950, librarians were debating how to correct errors in medical journals. We have seen considerable progress in this area in recent decades and most journals now have policies to correct errors, as well as for dealing with fraud and scientific misconduct, in research articles."
These JAMA Oncology comments and the Journal of Neuro-Oncology Editorial both source of and support the comments that I have made.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
